Welcome to the team - Kasper Nørskov Kragh

This week we are happy to welcome a brand new addition to the Symcel family, Kasper Kragh.

NEW PUBLICATION: Bacteria control their metabolism when going into biofilm formation

- This shift in metabolism has strong implications for tolerance to antibiotics

Invited to speak at the United States Pharmacopeia on probiotics

Today our Principal Scientist, Dr. Marta Veses Garcia will present at the United States Pharmacopeia event.

Symcel establishes US operation with headquarters in Boston

- The move brings Symcel closer to one of the world's biggest life science hubs 

Symcel raises 105 MSEK to develop rapid diagnostics to combat severe infections

– The funding will also accelerate the commercialization of Symcel’s R&D product offering (STOCKHOLM) Symcel — a company providing real-time metabolic measurements of living organisms with their analytical instrument the calScreener™  ̶  today...

NEW PUBLICATION: Giving antibiotics another chance in Cystic Fibrosis

– New antibiotic potentiating activity has been discovered for treatment of Cystic Fibrosis associate infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for bacteria and cell culture with their product the...

One step closer to a pill for weight loss without diet or exercise

– A new screening method will help to discover drugs that force the body to burn fat reserves. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently involved in...

NEW PUBLICATION: Fructose metabolism by cancer cells provides them with a survival benefit

– This metabolism has been directly measured for the first time using microcalorimetry (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently involved in a...

NEW PUBLICATION: calScreener shows efficacy of antibiotic treatments against group A streptococci in a complex mammalian cell model

– Metabolic readouts highlighted which treatment parameters were most effective. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently involved in a...

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis

(STOCKHOLM) Symcel — a company providing real-time metabolic measurements for cell culture with their product the calScreener™  ̶  was recently featured in a peer-reviewed publication showing that metastatic potential of certain tumours is related...